预付款项变动幅度为152.83%,原因:专用装备制造及安装产业购买重要原材料预付款项增加。 据证券之星公开数据整理，近期天通股份（600330）发布2025年中报。截至本报告期末，公司营业总收 入15.84亿元，同比上升1.0%，归母净利润5260.73万元，同比下降33.29%。按单季度数据看，第二季度 营业总收入8.69亿元，同比上升20.13%，第二季度归母净利润464.57万元，同比下降86.54%。本报告期 天通股份公司应收账款体量较大，当期应收账款占最新年报归母净利润比达2255.18%。 本次财报公布的各项数据指标表现一般。其中，毛利率20.63%，同比增0.25%，净利率3.33%，同比减 36.47%，销售费用、管理费用、财务费用总计1.8亿元，三费占营收比11.35%，同比增5.9%，每股净资 产6.5元，同比增0.57%，每股经营性现金流-0.05元，同比增60.89%，每股收益0.04元，同比减32.81% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 15.68亿 | 15.84 Z ...

据证券之星公开数据整理，近期恒实科技（300513）发布2025年中报。截至本报告期末，公司营业总收 入4.03亿元，同比下降28.66%，归母净利润-1.06亿元，同比下降107.87%。按单季度数据看，第二季度 营业总收入2.8亿元，同比下降38.24%，第二季度归母净利润-7452.65万元，同比下降79.97%。本报告期 恒实科技三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达32.82%。 | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 5.65 Z | 4.03亿 | -28.66% | | 归母浄利润（元） | -5095.78万 | -1.06 Z | -107.87% | | 扣非净利润(元) | -5133.17万 | -1.08亿 | -110.38% | | 货币资金(元) | 1.5亿 | 1 3.03亿 | 101.85% | | 应收账款(元) | 4.95亿 | 4.08亿 | -17.63% | | 有息负债(元) | 7.8亿 | 8.63亿 | 10.64 ...

据证券之星公开数据整理，近期天成自控（603085）发布2025年中报。截至本报告期末，公司营业总收 入11.56亿元，同比上升31.4%，归母净利润2327.09万元，同比上升47.55%。按单季度数据看，第二季 度营业总收入6.16亿元，同比上升20.39%，第二季度归母净利润235.16万元，同比下降59.11%。本报告 期天成自控短期债务压力上升，流动比率达0.9。 本次财报公布的各项数据指标表现尚佳。其中，毛利率16.63%，同比减18.75%，净利率2.01%，同比增 12.29%，销售费用、管理费用、财务费用总计9402.17万元，三费占营收比8.14%，同比减34.76%，每股 净资产2.15元，同比减5.11%，每股经营性现金流0.47元，同比增7536.42%，每股收益0.06元，同比增 50.0% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 8.8亿 | 11.56亿 | - 31.40% | | 归母净利润(元) | 1577.14万 | 2327.09万 | 47.55% | | 扣 ...

Core Viewpoint - ST Changyuan (600525) reported a decline in revenue and a significant increase in net loss for the first half of 2025, indicating financial distress and rising short-term debt pressure [1]. Financial Performance Summary - Total revenue for H1 2025 was 3.47 billion yuan, a decrease of 0.89% year-on-year [1]. - Net profit attributable to shareholders was -344 million yuan, a decline of 774.65% year-on-year [1]. - In Q2 2025, total revenue was 2.07 billion yuan, an increase of 11.95% year-on-year, while net profit was -252 million yuan, a decrease of 351.46% year-on-year [1]. - The gross margin was 32.94%, up 0.16% year-on-year, while the net margin was -10.64%, down 514.21% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 817 million yuan, accounting for 23.54% of revenue, a slight decrease of 0.38% year-on-year [1]. Key Financial Metrics - Earnings per share (EPS) was -0.26 yuan, a decrease of 772.24% year-on-year [1]. - Net asset value per share was 2.83 yuan, down 26.78% year-on-year [1]. - Operating cash flow per share was -0.17 yuan, an increase of 4.4% year-on-year [1]. Significant Changes in Financial Items - Cash and cash equivalents increased by 23.63% to 4.31 billion yuan, primarily due to increased bank acceptance bills and loan guarantees [1]. - Long-term equity investments decreased by 50.03% due to the transfer of 25% equity in Changyuan Electronics, resulting in a reduction of 622 million yuan [1]. - Construction in progress increased by 36.38% due to investments in new material parks and upgrades [1]. - Accounts payable increased by 79.51% due to increased bill issuance [1]. - The current ratio was 0.97, indicating rising short-term debt pressure [1]. Business Evaluation - The company's historical return on invested capital (ROIC) has been weak, with a median of 2.91% over the past decade and a low of -10.83% in 2021 [4]. - The business model relies heavily on research and marketing, necessitating careful examination of the underlying drivers [4]. - Recommendations include monitoring cash flow status and debt levels, as the liquidity ratio is only 44.45% and the current ratio is 0.97 [4].

Core Viewpoint - The financial performance of Aoto Electronics in the first half of 2025 shows a decline in main revenue but significant growth in net profit, indicating a mixed financial outlook for the company [1][4]. Financial Performance Summary - Main revenue for the first half of 2025 was 313 million yuan, a year-on-year decrease of 6.19% [1][4]. - Net profit attributable to shareholders was 8.32 million yuan, reflecting a year-on-year increase of 251.82% [1][4]. - Non-recurring net profit reached 9.52 million yuan, up 4702.07% year-on-year [1][4]. - In Q2 2025, the company reported a single-quarter main revenue of 128 million yuan, down 16.61% year-on-year [1][4]. - The single-quarter net profit attributable to shareholders was -5.28 million yuan, a decline of 400.31% year-on-year [1][4]. - The single-quarter non-recurring net profit was -0.94 million yuan, down 150.87% year-on-year [1][4]. Financial Ratios and Metrics - The company's debt ratio stood at 29.69% [1]. - Investment income was 6.03 million yuan, while financial expenses were -4.23 million yuan [1]. - Gross profit margin was 37.68%, a decrease of 2.74% year-on-year [7]. - Return on assets was 0.63%, an increase of 270.58% year-on-year [7]. - Earnings per share were 0.01 yuan, up 248.64% year-on-year [7]. - Operating cash flow per share was -0.10 yuan, down 3.64% year-on-year [7].

证券之星消息，中科创达2025年中报显示，公司主营收入32.99亿元，同比上升37.44%；归母净利润 1.58亿元，同比上升51.84%；扣非净利润1.36亿元，同比上升54.44%；其中2025年第二季度，公司单季 度主营收入18.31亿元，同比上升49.72%；单季度归母净利润6590.21万元，同比上升384.21%；单季度 扣非净利润4878.03万元，同比上升1613.93%；负债率19.0%，投资收益951.59万元，财务费用-3264.25 万元，毛利率33.16%。 销售毛利率 (%) 33.16 同比 -9.89% 诗资产收益率(%) 1.60 同比 +46.78% 每股营业收入(元) 7.17 同比 +37.19% 每股收益(元) 0.34 同比 +51.76% 每股净资产(元) 21.68 同比 +4.56% 每股经营性现金流(元) 0.58 同比 -7.62% l 数据评级 财报数据概要请见下图: 2023 2024 2025 ■ 营业总收入-中报(亿) ■ 单季度营业总收入-第二季度(亿) 一 归母净利润 一 归母净利润-中报(亿) 1.58 同比 +51.84% 单季度归母净利润 ...

Core Viewpoint - JiuYuan YinHai (002777) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year, indicating a positive growth trajectory for the company. Financial Performance Summary - Total revenue for the first half of 2025 reached 439 million yuan, an increase of 11.33% year-on-year [1] - Net profit attributable to shareholders was 29.95 million yuan, up 160.02% year-on-year [1] - In Q2 2025, total revenue was 232 million yuan, reflecting a 16.32% increase year-on-year, while net profit for the quarter was 15.05 million yuan, a staggering increase of 1354.05% year-on-year [1] - Gross margin improved to 43.98%, up 12.16% year-on-year, and net margin rose to 6.59%, an increase of 525.74% year-on-year [1] - Total operating expenses (sales, management, and financial expenses) amounted to 107 million yuan, accounting for 24.25% of revenue, a decrease of 12.38% year-on-year [1] Cash Flow and Receivables - The net cash flow from operating activities increased by 34.79%, attributed to a reduction in cash payments for goods and services compared to the previous period [2] - Accounts receivable represented a significant portion of the company's financials, with accounts receivable to net profit ratio reaching 607.91% [1][6] Investment and Return Metrics - The company's return on invested capital (ROIC) for the previous year was 4.46%, indicating moderate capital efficiency [4] - The average expected earnings per share for 2025 is projected at 0.26 yuan, with anticipated total earnings of 105 million yuan [4] Fund Holdings - The largest fund holding JiuYuan YinHai is the Golden Eagle Medical Health Industry A fund, which holds 992,600 shares and has shown a significant increase in value over the past year [5]

Core Viewpoint - The recent financial report of Chuangyitong (300991) shows a year-on-year increase in total revenue and a significant improvement in net profit, despite a rise in short-term debt pressure and a decrease in cash reserves [1][5]. Financial Performance - Total revenue for the first half of 2025 reached 329 million yuan, up 16.39% year-on-year [1]. - The net profit attributable to shareholders was -814,200 yuan, an increase of 66.51% compared to the previous year [1]. - The gross margin was 23.18%, down 3.02% year-on-year, while the net margin improved to -0.21%, an increase of 82.3% [1]. - The total of selling, administrative, and financial expenses was 39.58 million yuan, accounting for 12.04% of revenue, a decrease of 23.41% year-on-year [1]. Cash Flow and Debt - Operating cash flow per share was 0.37 yuan, up 69.64% year-on-year, indicating improved cash generation from operations [1][6]. - The current ratio stood at 0.87, reflecting increased short-term debt pressure [1][10]. - Cash and cash equivalents decreased by 63.5% due to reduced cash inflow from financing activities [7]. Changes in Key Financial Items - Accounts receivable increased by 13.18% to 172 million yuan, attributed to increased sales [1][3]. - Prepayments surged by 110.29%, indicating higher material payments [5]. - Long-term borrowings decreased by 31.85% due to repayments and reclassifications [4]. Business Model and Market Position - The company relies heavily on research and development for its performance, necessitating a thorough examination of the underlying drivers [9]. - The return on invested capital (ROIC) was 3.04%, indicating a relatively weak capital return compared to historical averages [8]. Analyst Expectations - Analysts project a net profit of 47 million yuan for 2025, with an average earnings per share of 0.33 yuan [10].

据证券之星公开数据整理，近期麦克奥迪（300341）发布2025年中报。截至本报告期末，公司营业总收 入6.91亿元，同比上升5.6%，归母净利润9177.48万元，同比上升18.46%。按单季度数据看，第二季度 营业总收入3.75亿元，同比上升5.34%，第二季度归母净利润5689.32万元，同比上升24.55%。本报告期 麦克奥迪应收账款上升，应收账款同比增幅达30.96%。 本次财报公布的各项数据指标表现尚佳。其中，毛利率40.57%，同比减3.23%，净利率12.95%，同比增 5.29%，销售费用、管理费用、财务费用总计1.3亿元，三费占营收比18.8%，同比减11.14%，每股净资 产3.62元，同比增7.69%，每股经营性现金流0.06元，同比减74.37%，每股收益0.18元，同比增18.5% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 6.54Z | 6.91亿 | 5.60% | | 归母净利润(元) | 7747.55万 | 9177.48万 | 18.46% | | 扣非净利润(元) ...

据证券之星公开数据整理，近期振东制药（300158）发布2025年中报。根据财报显示，振东制药净利润 同比下降74.13%。截至本报告期末，公司营业总收入14.57亿元，同比下降3.3%，归母净利润793.13万 元，同比下降74.13%。按单季度数据看，第二季度营业总收入7.02亿元，同比下降3.05%，第二季度归 母净利润677.41万元，同比下降10.35%。 筹资活动产生的现金流量净额变动幅度为51.11%,原因:偿还借款及回购股份资金减少。 证券之星价投圈财报分析工具显示： 业务评价：去年的净利率为-44.86%，算上全部成本后，公司产品或服务的附加值不高。从历史年报数 据统计来看，公司近10年来中位数ROIC为3%，中位投资回报较弱，其中最惨年份2024年的ROIC 为-30.18%，投资回报极差。公司历史上的财报非常一般，公司上市来已有年报14份，亏损年份4次，如 无借壳上市等因素，价投一般不看这类公司。 本次财报公布的各项数据指标表现不尽如人意。其中，毛利率51.15%，同比增3.26%，净利率0.45%， 同比减76.07%，销售费用、管理费用、财务费用总计6.54亿元，三费占营收比44.9 ...